AI assistant
Ascelia Pharma Major Shareholding Notification 2021
3132_iss_2021-05-05_bc8a1518-da97-46ba-aa49-ba92af6a7ad1.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Issuer Ascelia Pharma AB
Holder
Sunstone LSV General Partner II ApS, acting in its capacity as General Partner of Sunstone Life Science Ventures Fund II K/S
Instrument
Instrument Ordinary shares SE0010573113 Before the transaction Shares Data not given* Voting rights Data not given* Transaction Reason for major shareholding notification Corporate action Date 30/04/2021 Limit for number of shares 15 % Limit for number of votes 15 % After the transaction Quantity Shares 4,778,129 Directly held voting rights 0 Indirectly held voting rights 4,778,129 Percentage Directly held shares 13.81903 % Directly held voting rights 0 % Indirectly held voting rights 14.15361 %
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | 14.15361 % | 4,778,129 |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 |
||
| Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
||
| - Physically settled | ||
| - Cash settled | ||
| Total | 14.15361 % | 4,778,129 |
Chain of controlling companies
Voting rights % Voting rights Company
4,778,129 14.15361 Sunstone Life Science Ventures Fund II K/S
Group total holdings Voting rights 4,778,129
Percentage of voting rights 14.15361
Notes (other relevant informations according to law)
Notification is made due to increased number of shares and votes in Ascelia Pharma AB announced on April 30th, 2021, resulting in the holder falling below the 15 % equity and vote threshold.
Published
05/05/2021 09:30
*Source of information has chosen not to submit the data
CLOSE PRINT
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25